Center-Authored Papers

Filters: Author is Goldman, Bryan H  [Clear All Filters]
Journal Article
Tomblyn MB, Goldman BH, Thomas CR, Benedetti JK, Lenz H-J, Mehta V, Beeker T, Gold PJ, Abbruzzese JL, Blanke CD.  2012.  Cetuximab Plus Cisplatin, Irinotecan, and Thoracic Radiotherapy as Definitive Treatment for Locally Advanced, Unresectable Esophageal Cancer: A Phase-II Study of The SWOG (S0414).. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. Abstract
Gustafson HL, Yao S, Goldman BH, Lee K, Spier CM, Leblanc ML, Rimsza LM, Cerhan JR, Habermann TM, Link BK et al..  2014.  Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma.. American journal of hematology. Abstract
Redman MW, Goldman BH, LeBlanc M, Schott A, Baker LH.  2013.  Modeling the relationship between progression-free survival and overall survival: the phase II/III trial.. Clinical cancer research : an official journal of the American Association for Cancer Research. 19(10):2646-56. Abstract
Persky DO, Dornan D, Goldman BH, Braziel RM, Fisher RI, LeBlanc M, Maloney DG, Press OW, Miller TP, Rimsza LM.  2012.  Reply to "Fc gamma receptor 3a genotype in follicular lymphoma: the end of the story?" Haematologica. 2012;97(11):e45. Haematologica. 97(11):e46.
Leichman LP, Goldman BH, Bohanes PO, Lenz HJ, Thomas CR, Billingsley KG, Corless CL, Iqbal S, Gold PJ, Benedetti JK et al..  2011.  S0356: A Phase II Clinical and Prospective Molecular Trial With Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Before Surgery for Patients With Esophageal Adenocarcinoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(34):4555-60. Abstract